Cross-border fertility treatments are expanding rapidly as patients seek greater access, lower costs and reproductive services unavailable in their home countries
Fertility tourism is emerging as one of the fastest-growing segments of international medical travel. According to a new market analysis by The Business Research Company, the global market is expected to increase from $960 million in 2025 to $1.24 billion in 2026. The research firm estimates annual growth of almost 30%, driven by rising demand for assisted reproductive technologies and an increasingly international market for fertility services.
Behind the figures lies a highly personal form of travel. Patients cross national borders for treatments such as in-vitro fertilization and other assisted reproductive procedures, seeking specialist expertise, more affordable treatment or services that are restricted or unavailable in their countries of residence.
Market could almost triple by 2030
The Business Research Company forecasts that the fertility tourism market will reach $3.5 billion by 2030, corresponding to a compound annual growth rate of 29.5% between 2026 and 2030.
Several factors are expected to contribute to this expansion. Cross-border reproductive care networks are becoming more extensive, while assisted reproductive treatments are becoming accessible to a broader group of patients. Changing attitudes toward different family models and evolving regulatory environments in fertility tourism destinations are also influencing demand.
Digitalization could further reduce geographical barriers. Online fertility consultations and remote diagnostics allow parts of the patient journey to take place before travelers leave their home countries, while the actual medical procedures remain concentrated at specialized clinics abroad.
Technology reshapes cross-border fertility treatment
Technological developments are expected to become increasingly important in determining where patients seek treatment. The report identifies AI-assisted embryo selection and reproductive analytics among the trends likely to influence personalized IVF protocols.
International donor and surrogacy networks are also expanding, connecting patients with providers across national borders. At the same time, financing models such as installment payments and insurance-linked reproductive coverage could make costly treatments accessible to more patients.
Specialized fertility clinics equipped with advanced assisted reproductive technologies are consequently becoming an increasingly important component of the international medical tourism landscape.
Cost and regulation influence destination choices
Fertility tourism differs from many other forms of medical travel because national legislation can be as important as treatment quality and price. Patients may travel abroad because a particular reproductive procedure is legally restricted at home, because treatment is less expensive elsewhere or because specialist services are more readily available.
The expansion of medical tourism infrastructure has helped facilitate such journeys. According to the market analysis, increasing infertility rates, greater awareness of assisted reproductive technologies and the legalization of IVF and surrogacy in various countries have contributed to the sector's recent growth.
Health insurance could also influence future demand. Partial reimbursement, international treatment coverage and access to less expensive treatment abroad can reduce the financial burden associated with reproductive care. The report cites US Census Bureau data showing that private health insurance coverage in the United States increased by 0.7% between 2023 and 2024, largely due to growth in directly purchased plans.
Europe leads while Asia-Pacific gains ground
Europe accounted for the largest share of the global fertility tourism market in 2025, according to the report. The region combines established fertility clinics with relatively dense international transport networks and a diverse regulatory landscape that encourages some patients to seek treatment across national borders.
Asia-Pacific, however, is forecast to be the fastest-growing region during the coming years. The market analysis also covers Southeast Asia, Western and Eastern Europe, North and South America, the Middle East and Africa.
If the forecast materializes, fertility tourism will develop from a comparatively small niche of medical travel into a multibillion-dollar international market by the end of the decade, increasingly linking healthcare providers, tourism infrastructure and digital reproductive services across borders.
Image Credit: © AI generated illustration